[HTML][HTML] Knockout cancer by nano-delivered immunotherapy using perfusion-aided scaffold-based tumor-on-a-chip

P Suryavanshi, D Bodas - Nanotheranostics, 2024 - ncbi.nlm.nih.gov
Cancer is a multifactorial disease produced by mutations in the oncogenes and tumor
suppressor genes, which result in uncontrolled cell proliferation and resistance to cell death …

In vitro immunity: an overview of immunocompetent organ-on-chip models

AI Morrison, MJ Sjoerds, LA Vonk, S Gibbs… - Frontiers in …, 2024 - frontiersin.org
Impressive advances have been made to replicate human physiology in vitro over the last
few years due to the growth of the organ-on-chip (OoC) field in both industrial and academic …

Integrating transcriptomic and structural insights: revealing drug repurposing opportunities for sporadic ALS

N Sunildutt, F Ahmed, AR Chethikkattuveli Salih… - ACS …, 2024 - ACS Publications
Amyotrophic lateral sclerosis (ALS) is a progressive and devastating neurodegenerative
disorder characterized by the loss of upper and lower motor neurons, resulting in debilitating …

Genetically modified organoids for tissue engineering and regenerative medicine

Q Zhang, J He, D Zhu, Y Chen, M Fu, S Lu, Y Qiu… - Advances in Colloid and …, 2024 - Elsevier
To date, genetically modified organoids are emerging as a promising 3D modeling tool
aimed at solving genetically relevant clinical and biomedical problems for regenerative …

Toxicokinetic analysis of the highly toxic nerve agent VX in commercially available multi-organ-chips–Ways to overcome compound absorption

N Amend, M Koller, C Schmitt, F Worek - Toxicology Letters, 2024 - Elsevier
Organ-on-a-chip technology is considered a next-generation platform in pharmacology and
toxicology. Nevertheless, this novel technology still faces several challenges concerning the …

A microvascularized in vitro liver model for disease modeling and drug discovery

F Bonanini, R Dinkelberg, MC Torregrosa… - …, 2024 - iopscience.iop.org
Drug discovery for complex liver diseases faces alarming attrition rates. The lack of non-
clinical models that recapitulate key aspects of liver (patho)-physiology is likely contributing …

[HTML][HTML] Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment window

SB Çam, E Çiftci, N Gürbüz, B Altun… - Stem Cell Research & …, 2024 - Springer
Background Acute hypoxic proximal tubule (PT) injury and subsequent maladaptive repair
present high mortality and increased risk of acute kidney injury (AKI)-chronic kidney disease …

Advances in the Construction and Application of Bone‐on‐a‐Chip Based on Microfluidic Technologies

C Zhong, Z Tang, X Yu, L Wang, C Ren… - … Research Part B …, 2024 - Wiley Online Library
ABSTRACT Bone‐on‐a‐chip (BOC) models that based on microfluidic technology have
widely applied to understand bone physiology and the pathogenesis of related diseases. In …

Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling

CP Whitworth, WJ Polacheck - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Vascular diseases impart a tremendous burden on healthcare systems in the
United States and across the world. Efforts to improve therapeutic interventions are hindered …

[HTML][HTML] A weighted Bayesian integration method for predicting drug combination using heterogeneous data

T Li, L Xiao, H Geng, A Chen, YQ Hu - Journal of Translational Medicine, 2024 - Springer
Background In the management of complex diseases, the strategic adoption of combination
therapy has gained considerable prominence. Combination therapy not only holds the …